Morpheus8 RF Microneedling in Tokyo: A Practical Review and Guide to Cost
If you have started noticing softening along the jawline, crepey texture on the neck, or acne scars that never fully settled, you have probably come across Morpheus8 while searching for options in Tokyo. It is one of the more talked-about radiofrequency (RF) microneedling treatments, but the marketing around it rarely explains what the published evidence actually shows, or what determines the price you will be quoted.
This article gives an editorial overview of what Morpheus8 is, what the clinical literature supports, how it is regulated in Japan, and the realistic downtime and cost structure for patients treated in Tokyo.
What you’ll learn in this article:
- What Morpheus8 fractional RF microneedling is, and how it differs from needling without radiofrequency
- Its regulatory status in Japan versus the United States, and why the two are not the same thing
- What peer-reviewed studies report for acne scarring and for darker skin tones, with specific figures
- What drives the cost of a Morpheus8 course in Tokyo, and how downtime typically unfolds
- Who tends to be a suitable candidate, and who should consider a different approach
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
What Is Morpheus8, and How Does RF Microneedling Work?
Morpheus8 is a fractional radiofrequency microneedling device made by InMode. Very fine, insulated needles pass through the skin surface and deliver radiofrequency energy into the deeper layers, creating controlled zones of thermal injury that prompt the skin to remodel over the following weeks.
The distinguishing feature is depth control. Because the energy is released from the needle tips rather than applied to the surface, the practitioner can select how deep the effect is placed — on the clinic’s own treatment page, energy delivery of up to approximately 7.5 mm is described, depending on the applicator and the area being treated.
This matters clinically. A narrative review published in Plastic and Reconstructive Surgery – Global Open in March 2026 notes that RF microneedling produces “an electrothermal effect as opposed to a photothermal effect,” meaning that melanin is not the target chromophore as it is with many lasers. The review’s authors concluded that RF microneedling is safe for all skin types on that basis.
Regulatory status: the United States and Japan are not the same
In the United States, the FDA’s 510(k) database records clearance K192695 for the InMode System with the Morpheus8 (Fractora) Applicators, with a decision date of 27 December 2019, and a further clearance, K240017, for the Morpheus8 90 Applicator with a decision date of 13 June 2024. InMode announced the latter on 17 July 2024 as the first fractional RF microneedling clearance for contraction of soft tissue.
In Japan, Morpheus8 has not received approval under the Pharmaceutical and Medical Device Act. It is brought in through the physician-import route, which the Kinki Regional Bureau of Health and Welfare describes as importing for use by the physician “under their own responsibility” for their own patients, and only where no equivalent approved domestic product is already available.
Japan’s Ministry of Health, Labour and Welfare sets out how self-pay treatments using unapproved devices must be presented to the public in its Medical Advertising Guidelines, supported by a case-explanation document most recently issued on 30 March 2026. In practice, a clinic offering Morpheus8 in Japan should be telling you plainly that the device is unapproved domestically, how it was obtained, and what is known about its safety overseas.
Expected Results: What the Published Evidence Reports
The most frequently cited outcome data concerns acne.
A retrospective review published in Aesthetic Surgery Journal in 2025 compared three approaches across 356 patients: isotretinoin (n=128), ablative laser over six sessions (n=89), and fractional RF microneedling with Morpheus8 over three sessions (n=139).
Among the subset who completed three-year follow-up, relapse rates were 36 of 54 (67%) in the isotretinoin group, 12 of 16 (75%) in the laser group, and 7 of 29 (24%) in the fractional RF microneedling group. These are encouraging figures, but they come from a retrospective design with small follow-up subsets, so they should be read as suggestive rather than definitive.
For skin of colour specifically, the 2026 PRS Global Open review cites a study in which 58% of patients with Fitzpatrick types III–V showed moderate improvement in acne scarring, 9% good improvement, and 3% very good improvement. The review also recommends beginning at conservative energy settings in Fitzpatrick IV–VI and increasing gradually across a treatment course.
Realistically, clinical reports indicate that collagen remodelling continues for roughly three months after treatment, so results build progressively rather than appearing immediately. No device can guarantee a specific degree of tightening in any individual.
Morpheus8 Compared With Other Resurfacing and Tightening Options
| Option | How energy reaches the skin | Relevance to pigmented skin | Typical visible downtime |
|---|---|---|---|
| Morpheus8 (fractional RF microneedling) | Insulated needles deliver RF at a selected depth | Electrothermal; melanin is not the target chromophore | Redness and warmth for several days; pinpoint scabs possible |
| Microneedling without RF (e.g. Dermapen) | Mechanical needling only, no thermal energy | Does not disrupt the whole epidermis, so pigmentation risk is comparatively low | Usually shorter; most effects reported as transient |
| Non-ablative fractional laser | Light absorbed by tissue chromophores | Photothermal; requires more caution in darker skin types | Varies by device and settings |
| CO2 fractional laser | Ablative light energy removes microcolumns of tissue | Greater epidermal disruption; careful patient selection needed | Generally the longest of these options |
| HIFU | Focused ultrasound; no skin puncture | No needle entry points | Typically minimal surface downtime |
HIFU, CO2 fractional laser and Dermapen are all offered at BIOTOPE CLINIC in Shirokanedai alongside Morpheus8 — which of them suits a given face depends on whether the primary concern is laxity, texture, scarring or pigmentation. It is worth asking about the alternatives during a consultation with Dr. Karibe rather than assuming one device is the answer.
Cost in Tokyo: What Actually Drives the Price
Morpheus8 is a self-pay (自由診療) treatment. Because the device is not approved under Japan’s Pharmaceutical and Medical Device Act and the indication is aesthetic, it is not covered by Japanese national health insurance, and travel insurance will not normally reimburse it either.
Several variables move the number on the quotation:
- Treated area. Lower face and jawline, the under-chin area, the neck, or body zones are usually priced separately, and combined areas are priced as bundles.
- Applicator and depth. Different tips carry different pin counts and depth ranges; deeper body work is not priced the same as a delicate facial pass.
- Number of sessions. The clinic’s guidance describes a course of around three treatments spaced one to two months apart, so the meaningful figure is the course total, not the single-session price.
- Combination protocols. Morpheus8 is sometimes paired with subdermal RF such as Embrace RF, which changes both the clinical plan and the cost.
- Ancillary items. Topical anaesthesia, aftercare products and follow-up review may or may not be included.
Please see the clinic’s official price page or contact us for a current quote. Advertised single-session figures elsewhere are often campaign rates with conditions attached, so compare course totals rather than headline numbers. For an accurate quote, please book a consultation.
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
What to Expect: Before, During and After
At BIOTOPE CLINIC in Shirokanedai, a Morpheus8 consultation begins by establishing what is actually driving the concern — skin laxity, textural scarring, or volume change — because the answer determines the depth and energy plan, and sometimes points to a different treatment altogether.
On the day, topical anaesthetic cream is applied first; published guidance for needling procedures describes lidocaine cream applied roughly 30–60 minutes beforehand. The clinic’s treatment page gives a session time of approximately 30 to 60 minutes for the full face plus the under-chin area.
Downtime and aftercare
Expect redness and a flushed, warm sensation for a few days. Washing the face is generally possible from the day after treatment, and make-up from the following day once redness and stinging have settled; diligent moisturising and sun protection are advised throughout.
Documented risks include mild swelling, tenderness, bruising, pinpoint scabs and temporary roughness, along with pigmentary change. Less common but more serious complications include marked swelling, blistering and infection. Anyone travelling to Tokyo specifically for treatment should allow several days before any event where visible redness would be a problem.
Who is a good candidate, and who is not
Morpheus8 tends to suit people with mild to moderate laxity, textural irregularity or atrophic acne scarring who want remodelling without surgery and can commit to a course rather than a single visit. Because the mechanism is electrothermal rather than light-based, it is also considered across a broad range of skin tones, with more conservative settings recommended for Fitzpatrick IV–VI.
It is less appropriate where laxity is pronounced enough that only surgery will meaningfully address it, and it is not the right choice during active skin infection, over recently treated or inflamed skin, or in pregnancy. Patients with implanted electronic devices, a history of keloid scarring, or a melasma history should raise this at consultation, as thermal treatments can provoke pigmentary responses in susceptible skin.
What People Often Get Wrong About Morpheus8
“It is FDA-approved, so it must be approved in Japan too.”
These are unrelated regulatory systems. The FDA record shows 510(k) clearances — a substantial-equivalence pathway, not a premarket approval — and neither of those clearances has any bearing on Japanese status. In Japan the device remains unapproved and is used under the physician-import route, which is precisely why a compliant clinic must disclose that fact to you.
“Stacking devices in one session must work better.”
Not necessarily. A 2025 meta-analysis in Cureus pooled five randomised split-face trials covering 116 patients (232 facial sides) and found that adding fractional microneedling radiofrequency to non-ablative fractional laser produced a pooled odds ratio of 1.22 (95% CI 0.70–2.12, p=0.48) for achieving 50–75% improvement in atrophic acne scars — no statistically significant advantage over the laser alone, and no significant difference in side effects. Well-chosen settings on one appropriate device generally matter more than the number of devices used.
Where to Get Morpheus8 RF Microneedling in Tokyo
Within our clinic group, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology & Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Jun Karibe’s team.
Morpheus8 RF microneedling is handled at BIOTOPE CLINIC (Shirokanedai, Minato-ku). Bookings and enquiries in English: LINE or WhatsApp.
The two clinics are sister sites of the same medical group under Dr. Karibe, a plastic surgeon board-certified by the Japan Society of Plastic and Reconstructive Surgery. Kojimachi handles insurance-covered general dermatology — eczema, acne, rashes, warts and moles — as well as general and aesthetic plastic surgery, so if a skin complaint turns out to need medical rather than cosmetic treatment, it can be seen there.
Frequently Asked Questions
- Q. How many Morpheus8 sessions will I need?
- The clinic’s guidance describes a course of around three sessions spaced one to two months apart. The published acne study cited above also used a three-session protocol, though the number appropriate for you depends on your assessment findings.
- Q. Is Morpheus8 safe for Asian or darker skin tones?
- A 2026 narrative review in PRS Global Open describes RF microneedling as safe for all skin types, because it works by an electrothermal rather than photothermal effect and does not target melanin. Conservative starting energies with gradual increases are recommended for Fitzpatrick types IV–VI.
- Q. Can I fly home a day or two after treatment?
- Flying itself is not usually the issue, but visible redness and warmth commonly persist for several days, and pinpoint scabbing can occur. If you are visiting Tokyo, plan the session early in your stay and discuss timing at consultation.
- Q. Does Japanese health insurance cover it?
- No. Morpheus8 is an unapproved device in Japan used for aesthetic purposes, so treatment is entirely self-pay. Insurance-covered dermatology is a separate service handled at the Kojimachi clinic.
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
Summary
Morpheus8 is a fractional RF microneedling device with two US FDA 510(k) clearances, the most recent decided in June 2024, and a growing body of published data — most convincingly for atrophic acne scarring, where a retrospective series reported a 24% three-year relapse rate against 67% and 75% in comparator groups.
In Japan it remains an unapproved device used under physician import, which makes transparent disclosure and a proper consultation more important, not less. Cost depends on area, depth, applicator and the length of the course rather than any single headline figure, and downtime usually means several days of redness rather than weeks of recovery.
If you have questions about Morpheus8 RF microneedling, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology & Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Karibe and his team. Morpheus8 is primarily handled at BIOTOPE CLINIC. English enquiries: LINE or WhatsApp.
24/7 Consultation & Booking
Book a Consultation or Treatment
Our English-speaking team responds via LINE or WhatsApp — usually the same day.
References
- Hamadani F, Vranis NM. The Role of Fractional Radiofrequency in Long-term Acne Remission and Reduction of Acne Scar Load. Aesthetic Surgery Journal. 2025;45(Suppl 1):S23–S31.
- Lee SS, Burgener MM, Sayyed AA, et al. Noninvasive Cosmetic Treatments for Fitzpatrick IV–VI: A Narrative Review of Safety and Efficacy Guidelines. Plastic and Reconstructive Surgery – Global Open. 2026;14(3):e7541.
- Hassan Awaji HH, Bakhamees BH, Alruwaili M, et al. Comparing Combined Non-ablative Fractional Laser and Radiofrequency Microneedling Versus Non-ablative Fractional Laser Alone for Acne Scar Treatment: A Meta-Analysis. Cureus. 2025;17(12):e99900.
- U.S. Food and Drug Administration. 510(k) Premarket Notification Database — K192695 (InMode System with the Morpheus8 (Fractora) Applicators, decision 27 December 2019) and K240017 (InMode System with the Morpheus8 90 Applicator, decision 13 June 2024). https://www.fda.gov/
- Ministry of Health, Labour and Welfare, Japan. Medical Advertising Guidelines (医療広告ガイドライン) and accompanying website case-explanation document, issued 30 March 2026. https://www.mhlw.go.jp/
Related Articles
You may also find these articles useful.
- Morpheus8 RF Microneedling Tokyo: Cost & Results
- Embrace RF Tokyo: FaceTite + Morpheus8 Explained
- HIFU vs RF Microneedling: Treat Facial Sagging
- Skin Tightening Treatment Tokyo: Options and Cost
- Non-Surgical Facelift Tokyo: Embrace RF for 40s & 50s
SUPERVISED BY
Dr. Jun Karibe
MD
Director
Education & Career
Certifications
Awards
MEDICAL REVIEW
